NASDAQ: DARE - Daré Bioscience, Inc.

Доходность за полгода: +579.26%
Сектор: Healthcare

График акции Daré Bioscience, Inc.


О компании

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older.

Подробнее
Its products in advanced clinical development include Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder; and DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy. The company's Phase I-ready products are DARE-VVA1, a proprietary formulation of tamoxifen for intravaginal to treat vulvar vaginal atrophy in women with hormone-receptor positive breast cancer; DARE-PDM1, a proprietary hydrogel formulation of diclofenac, a nonsteroidal anti-inflammatory drug, for vaginal administration as a treatment for dysmenorrhea; DARE-204 and DARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-GML, an intravaginally-delivered potential multi-target antimicrobial agent formulated with glycerol monolaurate; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Выручка 0.01
EBITDA -0.0143
Число акций ао 0.0873 млрд
P/E 0.1809
P/S 12.23
P/BV 29.12
EV/EBITDA -0.6179
Цена ао 0.4983
ISIN US23666P1012
Сайт https://www.darebioscience.com
Валюта usd
IPO date 2014-04-10
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Изменение цены за день: +0.6069% (3.18)
Изменение цены за неделю: -2.16% (3.27)
Изменение цены за месяц: -7.27% (3.45)
Изменение цены за 3 месяца: +3.54% (3.09)
Изменение цены за полгода: +579.26% (0.471)
Изменение цены за год: +589.5% (0.464)
Изменение цены за 3 года: +84.93% (1.73)
Изменение цены за 5 лет: +299.91% (0.8)
Изменение цены с начала года: +680.32% (0.41)

Недооценка

Название Значение Оценка
P/S 0.855 9
P/BV -0.4756 0
P/E 0.1809 10
EV/EBITDA 0.0895 10
Итого: 7.38

Эффективность

Название Значение Оценка
ROA, % -141.72 0
ROE, % 597.53 10
Итого: 3.33

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA -0.1727 10
Итого: 10

Импульс роста

Название Значение Оценка
Доходность Revenue, % 3409.86 10
Доходность Ebitda, % 115.4 10
Доходность EPS, % 352.79 10
Итого: 10

Институционалы Объем Доля, %
Vanguard Group Inc 3448612 3.43
Geode Capital Management, LLC 971119 0.97
Renaissance Technologies, LLC 719400 0.72
Blackrock Inc. 402645 0.4
State Street Corporation 247710 0.25
Northern Trust Corporation 183302 0.18
Price (T.Rowe) Associates Inc 125900 0.13
Founders Financial Securities LLC 124000 0.12
Interwest Venture Management Co. 62065 0.06
HighTower Advisors, LLC 46700 0.05



Руководитель Должность Оплата Год рождения
Ms. Sabrina Martucci Johnson CEO, President, Principal Financial Officer, Secretary & Director 508.2k 1967 (57 лет)
Ms. Lisa Walters-Hoffert Executive Officer 469.2k 1959 (65 лет)
Mr. Mark Walters Vice President of Operations N/A 1955 (69 лет)
Ms. MarDee J. Haring-Layton Chief Accounting Officer N/A 1976 (48 лет)
Dr. David Friend Chief Scientific Officer N/A

Адрес: United States, San Diego. CA, 3655 Nobel Drive - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.darebioscience.com